Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Richard L Sidman
Affiliation
Harvard Medical School
ORCID
Career Start Year
1951
Papers
264
H Index
81
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35027678
Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats.
Mol Psychiatry
2022
33323946
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?
Pharmacogenomics J
2021
33870243
Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.
Med
2021
33758865
Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
bioRxiv
2021
33503971
A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases.
Cancers (Basel)
2021
33751590
Amphibian regeneration and mammalian cancer: Similarities and contrasts from an evolutionary biology perspective: Comparing the regenerative potential of mammalian embryos and urodeles to develop effective strategies against human cancer.
Bioessays
2021
34749885
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling.
Elife
2021
34060472
Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer.
Elife
2021
34234013
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Proc Natl Acad Sci U S A
2021
34330827
Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia.
Proc Natl Acad Sci U S A
2021
31130731
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
Cancer Gene Ther
2020
33219123
Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration.
Proc Natl Acad Sci U S A
2020
33004692
Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction.
JCI Insight
2020
32402283
A Biomarker for Predicting Responsiveness to Stem Cell Therapy Based on Mechanism-of-Action: Evidence from Cerebral Injury.
Cell Rep
2020
30476961
Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review.
JAMA Neurol
2019
31375630
Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
Proc Natl Acad Sci U S A
2019
30670660
A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina.
Proc Natl Acad Sci U S A
2019
29205207
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.
Pharmacogenomics J
2018
30209664
Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder.
Results Probl Cell Differ
2018
29720567
Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.
JCI Insight
2018
29490919
MLH1-rheMac hereditary nonpolyposis colorectal cancer syndrome in rhesus macaques.
Proc Natl Acad Sci U S A
2018
28652618
Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting.
Sci Rep
2017
28223512
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.
Proc Natl Acad Sci U S A
2017
28102462
Cerebellar Pathways in Mouse Model of Purkinje Cell Degeneration Detected by High-Angular Resolution Diffusion Imaging Tractography.
Cerebellum
2017
28428279
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.
Cancer Res
2017
28096400
Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation.
Proc Natl Acad Sci U S A
2017
28500272
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.
Proc Natl Acad Sci U S A
2017
28751581
Going viral? Linking the etiology of human prostate cancer to the <i>PCA3</i> long noncoding RNA and oncogenic viruses.
EMBO Mol Med
2017
28698375
BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.
Proc Natl Acad Sci U S A
2017
28548103
An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.
Cancer Gene Ther
2017
26839407
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
Proc Natl Acad Sci U S A
2016
26671631
Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
Neurosurgery
2016
27791181
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
Proc Natl Acad Sci U S A
2016
27791177
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.
Proc Natl Acad Sci U S A
2016
27189170
Brain endothelial cell-targeted gene therapy of neurovascular disorders.
EMBO Mol Med
2016
27317903
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.
Am J Pathol
2016
26912667
Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.
Mol Cell Proteomics
2016
26858439
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors.
Proc Natl Acad Sci U S A
2016
26884209
AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.
Proc Natl Acad Sci U S A
2016
26772878
Ligand-targeted theranostic nanomedicines against cancer.
J Control Release
2016
25775553
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch.
Proc Natl Acad Sci U S A
2015
26468327
The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.
Sci Transl Med
2015
26056266
Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.
Proc Natl Acad Sci U S A
2015
26080435
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
Proc Natl Acad Sci U S A
2015
25659743
Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis.
Proc Natl Acad Sci U S A
2015
25675522
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer.
Proc Natl Acad Sci U S A
2015
25623065
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.
J Biol Chem
2015
25640897
Ligand-directed profiling of organelles with internalizing phage libraries.
Curr Protoc Protein Sci
2015
25762070
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.
Proc Natl Acad Sci U S A
2015
24496871
Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia.
Cancer
2014
1 - 50 of 264
Column Actions
Search
Recommended Authors
Vicente Herranz-P??rez
Cavanilles Institute, University of Valencia
Career Start Year
2006
Number of shared co-authors
0
Seth Blackshaw
Johns Hopkins University School of Medicine.
Career Start Year
1994
Number of shared co-authors
1
Paul Olivier
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year
1993
Number of shared co-authors
0
Eric J Huang
University of California san francisco
Career Start Year
1990
Number of shared co-authors
1
Edwin S Monuki
University of California, University of California Irvine
Career Start Year
1989
Number of shared co-authors
3
Sebastian Brandner
UCL Queen Square Institute of Neurology
Career Start Year
1989
Number of shared co-authors
1
Dragan Maric
National Institute of Neurological Disorders and Stroke
Career Start Year
1986
Number of shared co-authors
1
Robert F Hevner
university of california san diego School of Medicine, University of California
Career Start Year
1986
Number of shared co-authors
2
Fran??ois Guillemot
the Francis Crick Institute
Career Start Year
1986
Number of shared co-authors
2
James Pickel
National Institute of Mental Health
Career Start Year
1986
Number of shared co-authors
0
Wolfgang Wurst
Institute of Developmental Genetics, German Research Center for Environmental Health
Career Start Year
1984
Number of shared co-authors
1
David H Rowitch
Wellcome Trust-Medical Research Council Stem Cell Institute and.
Career Start Year
1983
Number of shared co-authors
4
Jos?? Manuel Garc??a-Verdugo
Cavanilles Institute, University of Valencia
Career Start Year
1981
Number of shared co-authors
0
Constance L Cepko
Howard Hughes Medical Institute, Harvard Medical School
Career Start Year
1981
Number of shared co-authors
2
Robert W Williams
Mayo Clinic
Career Start Year
1981
Number of shared co-authors
5
Nathaniel Heintz
Howard Hughes Medical Institute, The Rockefeller University
Career Start Year
1980
Number of shared co-authors
1
Alan Mackay-Sim
Northern Clinical School, Sydney Medical School, University of Sydney
Career Start Year
1980
Number of shared co-authors
0
Ann M Flenniken
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year
1980
Number of shared co-authors
0
Greg Lemke
Salk Institute for Biological Studies
Career Start Year
1980
Number of shared co-authors
1
Derek van der Kooy
University of Toronto
Career Start Year
1977
Number of shared co-authors
0
John W Bigbee
Virginia Commonwealth University
Career Start Year
1977
Number of shared co-authors
1
John C Roder
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year
1975
Number of shared co-authors
0
Lawrence S B Goldstein
university of california san diego
Career Start Year
1975
Number of shared co-authors
1
Arnold R Kriegstein
University of California san francisco
Career Start Year
1974
Number of shared co-authors
0
Mark H Ellisman
National Center for Microscopy and Imaging Research, University of California
Career Start Year
1974
Number of shared co-authors
3
Xandra O Breakefield
Massachusetts General Hospital
Career Start Year
1973
Number of shared co-authors
4
William C Mobley
University of California San Diego
Career Start Year
1973
Number of shared co-authors
2
Dan Goldowitz
University of British Columbia
Career Start Year
1972
Number of shared co-authors
1
E. Tessa Hedley-Whyte
Massachusetts General Hospital, Harvard Medical School
Career Start Year
1965
Number of shared co-authors
2
Constantino Sotelo
Institut de la Vision, Sorbonne Universite, INSERM, CNRS
Career Start Year
1959
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Wadih Arap
Rutgers Cancer Institute of New Jersey
Co-authored papers
63
Renata Pasqualini
Rutgers Cancer Institute of New Jersey
Co-authored papers
62
Evan Y Snyder
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
30
Fernanda I Staquicini
Rutgers Cancer Institute of New Jersey
Co-authored papers
21
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Co-authored papers
16
Ricardo J Giordano
Institute of Chemistry, University of Sao Paulo
Co-authored papers
11
Emmanuel Dias-Neto
A.C. Camargo Cancer Center
Co-authored papers
8
Michael G Ozawa
Stanford University School of Medicine
Co-authored papers
7
Wouter H P Driessen
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
7
Diana N Nunes
A.C. Camargo Cancer Center
Co-authored papers
7
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers
6
Elena M Barbu
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
6
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Co-authored papers
5
Mary E Hatten
The Rockefeller University
Co-authored papers
4
Stephen K Burley
The State University of New Jersey
Co-authored papers
3
Eleni Efstathiou
Houston Methodist Cancer Center
Co-authored papers
3
Mian M Alauddin
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Nora M Navone
MD Anderson Cancer Center
Co-authored papers
3
Jo??o C Setubal
Chemistry Institute, Universidade de Sao Paulo - USP
Co-authored papers
2
Leo G Flores
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Ross Zafonte
Spaulding Rehabilitation Hospital, Harvard Medical School
Co-authored papers
2
Joseph T Coyle
Harvard Medical School and McLean Hospital
Co-authored papers
2
Franz-Josef Müller
Co-authored papers
2
Jorge Cortes
Georgia Cancer Center
Co-authored papers
2
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers
2
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
2
Cristian G Bologa
University of New Mexico School of Medicine
Co-authored papers
2
Suren Soghomonyan
The Ohio State University Wexner Medical Center
Co-authored papers
2
Albert J Fornace
Co-authored papers
2
1 - 30